Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
DDIT4L regulates mitochondrial and innate immune activities in early life
Christina Michalski, Claire Cheung, Ju Hee Oh, Emma Ackermann, Constantin R. Popescu, Anne-Sophie Archambault, Martin A. Prusinkiewicz, Rachel Da Silva, Abdelilah Majdoubi, Marina Viñeta Paramo, Rui Yang Xu, Frederic Reicherz, Annette E. Patterson, Liam Golding, Ashish A. Sharma, Chinten J. Lim, Paul C. Orban, Ramon I. Klein Geltink, Pascal M. Lavoie
Christina Michalski, Claire Cheung, Ju Hee Oh, Emma Ackermann, Constantin R. Popescu, Anne-Sophie Archambault, Martin A. Prusinkiewicz, Rachel Da Silva, Abdelilah Majdoubi, Marina Viñeta Paramo, Rui Yang Xu, Frederic Reicherz, Annette E. Patterson, Liam Golding, Ashish A. Sharma, Chinten J. Lim, Paul C. Orban, Ramon I. Klein Geltink, Pascal M. Lavoie
View: Text | PDF
Research Article Immunology

DDIT4L regulates mitochondrial and innate immune activities in early life

  • Text
  • PDF
Abstract

Pattern recognition receptor responses are profoundly attenuated before the third trimester of gestation in the relatively low-oxygen human fetal environment. However, the mechanisms regulating these responses are uncharacterized. Herein, genome-wide transcription and functional metabolic experiments in primary neonatal monocytes linked the negative mTOR regulator DDIT4L to metabolic stress, cellular bioenergetics, and innate immune activity. Using genetically engineered monocytic U937 cells, we confirmed that DDIT4L overexpression altered mitochondrial dynamics, suppressing their activity, and blunted LPS-induced cytokine responses. We also showed that monocyte mitochondrial function is more restrictive in earlier gestation, resembling the phenotype of DDIT4L-overexpressing U937 cells. Gene expression analyses in neonatal granulocytes and lung macrophages in preterm infants confirmed upregulation of the DDIT4L gene in the early postnatal period and also suggested a potential protective role against inflammation-associated chronic neonatal lung disease. Taken together, these data show that DDIT4L regulates mitochondrial activity and provide what we believe to be the first direct evidence for its potential role supressing innate immune activity in myeloid cells during development.

Authors

Christina Michalski, Claire Cheung, Ju Hee Oh, Emma Ackermann, Constantin R. Popescu, Anne-Sophie Archambault, Martin A. Prusinkiewicz, Rachel Da Silva, Abdelilah Majdoubi, Marina Viñeta Paramo, Rui Yang Xu, Frederic Reicherz, Annette E. Patterson, Liam Golding, Ashish A. Sharma, Chinten J. Lim, Paul C. Orban, Ramon I. Klein Geltink, Pascal M. Lavoie

×

Figure 3

DDIT4L overexpression alters mitochondrial dynamics, suppresses mitochondrial activity, and inhibits cell proliferation and LPS cytokine responses in U937 cell clones.

Options: View larger image (or click on image) Download as PowerPoint
DDIT4L overexpression alters mitochondrial dynamics, suppresses mitochon...
(A) Schematic representation of the generation of DDIT4L-overexpressing U937 clones. (B) DDIT4L protein expression, (C) cell count, (D) cell viability and (E) mitochondrial mass (by flow cytometry), and (G) spare respiratory capacity (by mitochondrial stress test on Seahorse analyzer) following culture of single-cell-sorted selected DDIT4L- or empty vector–transduced (EV-transduced) U937 cell clones for 72 hours in the presence of rapamycin (rap, 10 ng/mL), doxycycline (dox, 100 ng/mL), or a corresponding concentration of DMSO, as control (ctrl). Data are from 6 EV and 12 DDIT4L independent cell clones in B–D, 4 EV and 4 DDIT4L independent cell clones for E and G, and 6 EV and 6 DDIT4L independent cell clones for F and H–N (representative data from 1 of 3 experiments, using separate batches of the same clones). (L) DDIT4L expression (by flow cytometry), (M) IL-8, and (N) TNF-α production (by ELISA) in PMA-differentiated (48 hours) DDI4L- or EV-transduced U937 cell clones treated overnight with rap, dox, or control conditions followed by LPS stimulation for 5 hours. Protein expression of mitochondrial fission and fusion markers: (F) TOM20, (H) MFF, (I) MFN2, (J) DRP1 phosphorylatioin and (K) DRP1 (Supplemental Figure 8 for corresponding Western blots) in DDI4L- or EV-transduced U937 cell clones after overnight culture in the presence of dox or DMSO control conditions. Data are presented as boxes (25th to 75th percentile) and whiskers (minimum to maximum), with solid lines indicating the median, normalized to DMSO conditions. P values were calculated using 2-sided unpaired t tests for specific differences between EV-dox and DDIT4L-dox experimental conditions (Welch’s correction was applied to B and L due to unequal variances between the 2 comparison groups; data for DDIT4L expression in L was log transformed prior to statistical testing). Only relevant comparisons between EV-dox and DDIT4L-dox are show for simplicity. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts